Home

Bioworkshops sell "Fremanezumab"

Basic Information

628
26
15
4.2(15)

Trade Type

Sell

Product Name

Fremanezumab

Manufacturer(s)

Specifications

  • Expression System: Recombinant mammalian (CHO) cell line expression, optimized for high-titer productivity
  • Purity: High analytical comparability to reference product, consistent with mAb purity standards (typically ≥95% monomer by SEC-HPLC)
  • Formulation Type: Liquid formulation intended for subcutaneous injection, humanized IgG2 monoclonal antibody
  • Storage Condition: Store refrigerated at 2-8°C, protect from light; do not freeze
  • Regulatory Status: Developed from a cell line with DMF filing in place, supporting global regulatory submissions; reference product (Ajovy) approved by FDA on 2018-09-14
  • Application: CGRP antagonist monoclonal antibody for the preventive treatment of migraine in adults

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product